NODK vs. CLOV, IGIC, TIPT, AMBC, HIPO, GOCO, KFS, HRTG, VERY, and ZBAO
Should you be buying NI stock or one of its competitors? The main competitors of NI include Clover Health Investments (CLOV), International General Insurance (IGIC), Tiptree (TIPT), Ambac Financial Group (AMBC), Hippo (HIPO), GoHealth (GOCO), Kingsway Financial Services (KFS), Heritage Insurance (HRTG), Vericity (VERY), and Zhibao Technology (ZBAO). These companies are all part of the "insurance" industry.
NI (NASDAQ:NODK) and Clover Health Investments (NASDAQ:CLOV) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their dividends, community ranking, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.
NI has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than NI, indicating that it is currently the more affordable of the two stocks.
NI received 64 more outperform votes than Clover Health Investments when rated by MarketBeat users. Likewise, 62.04% of users gave NI an outperform vote while only 39.62% of users gave Clover Health Investments an outperform vote.
Clover Health Investments has a consensus price target of $1.50, suggesting a potential downside of 13.29%. Given Clover Health Investments' higher probable upside, analysts plainly believe Clover Health Investments is more favorable than NI.
21.9% of NI shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 1.2% of NI shares are owned by company insiders. Comparatively, 22.3% of Clover Health Investments shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
In the previous week, Clover Health Investments had 3 more articles in the media than NI. MarketBeat recorded 5 mentions for Clover Health Investments and 2 mentions for NI. NI's average media sentiment score of 0.93 beat Clover Health Investments' score of 0.72 indicating that NI is being referred to more favorably in the media.
NI has a net margin of 1.37% compared to Clover Health Investments' net margin of -8.63%. NI's return on equity of 2.11% beat Clover Health Investments' return on equity.
NI has a beta of 0.36, suggesting that its share price is 64% less volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 2.11, suggesting that its share price is 111% more volatile than the S&P 500.
Summary
NI beats Clover Health Investments on 11 of the 16 factors compared between the two stocks.
Get NI News Delivered to You Automatically
Sign up to receive the latest news and ratings for NODK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NODK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools